Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIO-TRADE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 3.5% 3.5%   Bankruptcy risk   1.7% 3.1% 1.3% 1.2% 1.7% 1.1% 9.4% 9.4%   Credit score (0-100)   74 57 80 82 72 82 26 26   Credit rating   A BBB A A A A BB BB   Credit limit (kDKK)   2.0 0.0 38.4 108.9 2.9 156.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,329 1,416 2,592 2,447 2,188 2,707 0.0 0.0   EBITDA   456 117 863 823 588 983 0.0 0.0   EBIT   431 74.5 817 735 430 826 0.0 0.0   Pre-tax profit (PTP)   410.9 64.2 789.1 717.9 425.4 757.0 0.0 0.0   Net earnings   304.7 44.9 616.2 558.6 248.4 694.9 0.0 0.0   Pre-tax profit without non-rec. items   411 64.2 789 718 425 757 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   220 199 382 697 540 382 0.0 0.0   Shareholders equity total   1,308 1,353 1,969 2,528 2,776 3,471 3,189 3,189   Interest-bearing liabilities   52.4 58.4 57.4 57.4 57.4 50.0 0.0 0.0   Balance sheet total (assets)   2,693 2,206 3,172 4,236 4,616 4,480 3,189 3,189   Net Debt   -229 -50.6 -398 -540 -554 -304 -3,189 -3,189     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,329 1,416 2,592 2,447 2,188 2,707 0.0 0.0   Gross profit growth   19.7% -39.2% 83.0% -5.6% -10.6% 23.7% -100.0% 0.0%   Employees   6 4 4 4 4 4 0 0   Employee growth %   0.0% -33.3% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,693 2,206 3,172 4,236 4,616 4,480 3,189 3,189   Balance sheet change%   39.1% -18.1% 43.8% 33.5% 9.0% -2.9% -28.8% 0.0%   Added value   456.4 117.2 863.0 823.2 518.6 982.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   28 -64 137 227 -314 -314 -382 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   18.5% 5.3% 31.5% 30.0% 19.7% 30.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.6% 3.0% 30.4% 19.8% 9.7% 18.2% 0.0% 0.0%   ROI %   34.1% 5.2% 45.9% 30.8% 15.2% 25.2% 0.0% 0.0%   ROE %   26.4% 3.4% 37.1% 24.8% 9.4% 22.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   48.6% 61.3% 62.1% 59.7% 66.9% 77.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -50.2% -43.2% -46.1% -65.6% -94.3% -31.0% 0.0% 0.0%   Gearing %   4.0% 4.3% 2.9% 2.3% 2.1% 1.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   24.5% 18.7% 48.7% 29.9% 8.7% 127.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 0.6 0.8 0.8 1.3 1.3 0.0 0.0   Current Ratio   0.9 0.6 0.8 0.8 0.9 1.3 0.0 0.0   Cash and cash equivalent   281.6 109.0 455.4 597.3 611.7 354.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -196.3 -298.8 -240.0 -383.6 -153.5 314.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   76 29 216 206 130 246 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   76 29 216 206 147 246 0 0   EBIT / employee   72 19 204 184 108 206 0 0   Net earnings / employee   51 11 154 140 62 174 0 0